New eye drop could stop pterygium growth without surgery
Disease control
Ongoing
This Phase 3 trial tests CBT-001 eye drops against a placebo in 660 people with pterygium, a non-cancerous growth on the eye's surface. The goal is to see if the drops can reduce redness and stop the growth from getting bigger over 24 months. If successful, it could offer a drug-…
Phase: PHASE3 • Sponsor: Cloudbreak Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC